植入物与自体组织乳房再造:55,455例患者手术方式比较的系统综述与Meta分析
该系统综述与Meta分析比较了植入物乳房再造(IBR)与自体乳房再造(ABR),纳入32项研究共55,455例患者,检索至2021年9月。ABR在美学满意度(MD -8.51)和整体再造治疗满意度(MD -6.56)上显著更优;两组并发症率无显著差异(OR 1.06);ABR费用显著更高(SMD -0.69)。
要点
- ABR的美学满意度显著优于IBR(MD -8.51,95%CI -10.70至-6.33,p<0.001)。
- ABR的整体再造治疗满意度显著优于IBR(MD -6.56,95%CI -9.97至-3.14,p<0.001)。
- 两组并发症率无显著差异(OR 1.06,95%CI 0.71至1.59,p=0.76),ABR费用显著更高(SMD -0.69,95%CI -1.21至-0.17,p=0.010)。
核心结论
- ABR在美学满意度和整体再造治疗满意度上显著优于IBR,两组安全性相当,但ABR费用显著更高。
- 作者认为该研究结果有助于理解患者可被分配的不同临床路径,并强调了两种方法各自的优缺点。
研究设计与样本
- 系统综述与Meta分析,纳入32项比较IBR与ABR的研究,共55,455例患者。
- 检索MEDLINE/PubMed、ScienceDirect、EMBASE、BIOSIS、SciELO、Scopus和Web of Science数据库,检索时间为2021年9月。
- 提取组别特征、BREAST-Q评分、并发症率、住院时间(LOS)和费用数据;随机研究采用Cochrane偏倚风险工具,其他研究采用纽卡斯尔-渥太华队列研究质量评估量表。
主要发现
- ABR的美学满意度显著优于IBR(MD -8.51;95%CI -10.70至-6.33;p<0.001)。
- ABR的整体再造治疗满意度显著优于IBR(MD -6.56;95%CI -9.97至-3.14;p<0.001)。
- 两组并发症率无显著差异(OR 1.06;95%CI 0.71至1.59;p=0.76)。
- ABR费用显著更高(SMD -0.69;95%CI -1.21至-0.17;p=0.010)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The choice of reconstruction type is of utmost importance in treating breast cancer. There are two major reconstructive pathways in this group of patients: autologous breast reconstruction (ABR) and implant-based breast reconstruction (IBR). The aim of this systematic review and meta-analysis was to assess and compare IBR vs. ABR. METHODS: A review of studies reporting the differences between the procedures was performed. The MEDLINE/PubMed, ScienceDirect, EMBASE, BIOSIS, SciELO, Scopus, and Web of Science databases were thoroughly searched in September 2021. The data concerning group characteristics, BREAST-Q scores, complication rates, length of stay (LOS), and costs were extracted. The Cochrane risk-of-bias tool was used for randomized studies, while Newcastle-Ottawa Quality Assessment for Cohort Studies was used for other types of research. RESULTS: Our meta-analysis included 32 studies (n = 55,455). We observed significantly better outcomes following ABR when it comes to esthetic satisfaction (mean difference [MD] -8.51; 95% confidence interval [CI] -10.70, -6.33; p<0.001) and satisfaction with the entire reconstructive treatment (MD -6.56; 95% CI -9.97, -3.14; p<0.001). Both methods appeared to be comparable in terms of safety, while the complication rates varied insignificantly between the groups (odds ratio [OR] 1.06; 95% CI 0.71, 1.59; p = 0.76). ABR seems to be correlated with significantly higher costs (standard mean difference [SMD] -0.69; 95% CI -1.21, -0.17; p = 0.010). CONCLUSIONS: The results obtained from this evidence-based study will improve the understanding of the different clinical pathways that patients can be assigned to. The study emphasized the advantages and disadvantages of both methods.
引用
- Stefura T, Rusinek J, Wątor J, et al. Implant vs. autologous tissue-based breast reconstruction: A systematic review and meta-analysis of the studies comparing surgical approaches in 55,455 patients. J Plast Reconstr Aesthet Surg. 2022. PMID: 36621238. doi:10.1016/j.bjps.2022.11.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。